Svoronos Dawn 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-09+40,000→ 40,000 totalExercise: $1.56Exp: 2033-06-08→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 9, 2024 or the 2024 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.